LifeMD Inc
For the period ended Dec 31, 2024. Filed Mar 11, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 11, 2025
LFMD$2.10-11.6%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Operations
| Year Ended December 31, | ||
|---|---|---|
| 2024 | 2023 | |
| Revenues | ||
| Telehealth revenue, net | $158,438,631 | $98,152,919 |
| WorkSimpli revenue, net | 54,015,207 | 54,394,087 |
| Total revenues, net | 212,453,838 | 152,547,006 |
| Cost of revenues | ||
| Cost of telehealth revenue | 21,440,799 | 17,480,533 |
| Cost of WorkSimpli revenue | 2,627,680 | 1,419,931 |
| Total cost of revenues | 24,068,479 | 18,900,464 |
| Gross profit | 188,385,359 | 133,646,542 |
| Expenses | ||
| Selling and marketing expenses | 103,020,025 | 76,451,466 |
| General and administrative expenses | 72,662,021 | 51,694,232 |
| Customer service expenses | 10,217,654 | 7,632,283 |
| Development costs | 9,512,308 | 6,060,513 |
| Other operating expenses | 9,118,032 | 6,297,321 |
| Total expenses | 204,530,040 | 148,135,815 |
| Operating loss | (16,144,681) | (14,489,273) |
| Interest expense, net | (2,181,817) | (2,596,586) |
| Loss on debt extinguishment | - | (325,198) |
| Loss from operations before income taxes | (18,326,498) | (17,411,057) |
| Income tax provision | (402,000) | (428,000) |
| Net loss | (18,728,498) | (17,839,057) |
| Net income attributable to non-controlling interest | 153,234 | 2,756,935 |
| Net loss attributable to LifeMD, Inc. | (18,881,732) | (20,595,992) |
| Preferred stock dividends | (3,106,250) | (3,106,250) |
| Net loss attributable to LifeMD, Inc. common stockholders | $(21,987,982) | $(23,702,242) |
| Basic loss per share attributable to LifeMD, Inc. common stockholders | $(0.53) | $(0.70) |
| Diluted loss per share attributable to LifeMD, Inc. common stockholders | $(0.53) | $(0.70) |
| Weighted average number of common shares outstanding: | ||
| Basic | 41,196,292 | 33,905,155 |
| Diluted | 41,196,292 | 33,905,155 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.